1,324 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
ONCE Spark Therapeutics, Inc. $57.05 $2.14B N/A
Article Searches
Genworth's Merger with Oceanwide Pushed Back Once Again http://www.zacks.com/stock/news/686213/genworths-merger-with-oceanwide-pushed-back-once-again?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-686213 Dec 24, 2019 - The merger of Genworth (GNW) and Oceanwide has been pushed back for the 13th time due to regulatory requirements.
A Jewish Christmas wish: Let’s replace replacement theology once and for all http://www.nydailynews.com/opinion/ny-oped-a-jewish-christmas-wish-20191222-753yiq27yva4vf23gjzd7numwy-story.html Dec 22, 2019 -

Jews of my father’s generation, at least a good deal of them, dreaded Christmas. Today my family enjoys the holiday, fearlessly feasting at Chinese restaurants. Jews and Christians now live and celebrate in peace because Christians have largely abandoned replacement theology.

This Christmas I invite...

Vermont man who once crushed seven police vehicles with a tractor threatened to kill his family online http://www.nydailynews.com/news/crime/ny-vermont-man-roger-pion-kill-family-police-cruisers-tractor-20191220-itmbg24ekfdz5h532kwyfjygjq-story.html Dec 20, 2019 -

A lot of people get annoyed with family members over the holidays, but not everyone threatens to kill them online. And those who do probably haven’t at some point used a farm tractor to run over six police cruisers and a van.

That’s where Roger Pion is different.

The 41-year-old Newport, Vt., man...

Concert Pharma reports positive data on once-daily dosing of CTP-543 https://seekingalpha.com/news/3527559-concert-pharma-reports-positive-data-on-daily-dosing-of-ctpminus-543?utm_source=feed_news_all&utm_medium=referral Dec 19, 2019 - Results from a just-completed Phase 2 clinical trial comparing two dosing regimens (8 mg twice daily vs. 16 mg once daily) of Concert Pharmaceuticals' (NASDAQ:CNCE) CTP-543 in patients with moderate-t
ams AG Seemingly Going In All Directions At Once https://seekingalpha.com/article/4313207-ams-ag-seemingly-going-in-all-directions?source=feed_all_articles Dec 18, 2019 - ams is moving forward with the Osram acquisition, even though substantial uncertainties remain with respect to cost savings and real revenue/technology synergies.The core business is picking up, with
Analyst says FedEx plunge leaves bellwether vulnerable to the once unthinkable: an activist https://www.cnbc.com/2019/12/18/fedex-face-plant-could-make-it-open-to-an-activist-investor.html Dec 18, 2019 - FedEx's second-quarter results were so bad that it could spark interest among activist investors looking to turn the company around.
Asbestos, Quebec considers changing name from product for which it was once known http://www.startribune.com/asbestos-quebec-considers-changing-name-from-product-for-which-it-was-once-known/566285252/ Dec 17, 2019 -
Market Volatility Bulletin: Spot VIX Once Again Nears 11-Handle Territory As Dec VX Heads For Expiry https://seekingalpha.com/article/4312831-market-volatility-bulletin-spot-vix-again-nears-11-handle-territory-dec-vx-heads-for-expiry?source=feed_all_articles Dec 16, 2019 - Stocks are off to new highs as traders prepare for the Santa rally.  Each of the sector SPDRs is in positive territory.Bears can indeed emerge from anywhere, but we may need a new catalyst.  Until the
Once world's largest automaker, GM retreats overseas as other companies take the lead https://www.cnbc.com/2019/12/16/once-worlds-largest-automaker-gm-retreats-overseas-as-others-take-the-lead.html Dec 16, 2019 - Since taking the helm about six years ago, CEO Mary Barra has followed a strategy that might be referred to as one of strategic retrenchment, abandoning a number of once-critical markets, including Western Europe, India and, most recently, Russia.
Once Shunned For Marketing Approval, Golodirsen Is Now A Major Win For Sarepta https://seekingalpha.com/article/4312524-shunned-for-marketing-approval-golodirsen-is-now-major-win-for-sarepta?source=feed_sector_healthcare Dec 14, 2019 - Sarepta Therapeutics announced that it had received accelerated FDA approval for its DMD drug golodirsen.Golodirsen is expected to treat up to 8% of the entire duchenne muscular dystrophy population.T

Pages: 12345678...133

<<<Page 3>